1995 IPO

DaVita Stock

A leading provider of kidney care.

Sign up today and learn more about DaVita Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About DaVita Stock

DaVita a FORTUNE 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2012, DaVita operated or provided administrative services at 1,884 outpatient dialysis centers located in the United States, serving approximately 149,000 patients. The company also operated 19 outpatient dialysis centers located in four countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.


Senior Application Developer

Benjamin Snider

Interim Chief Financial Officer & Chief Accounting Officer

James Hilger

Chairman and CEO

Kent Thiry

IT Director

Jason Richling

Chief Compliance Officer

Jeanine Jiganti

Director, Strategy and Special Projects

Brannan Schell

Vice President of Clinical Affairs

John Wigneswaran

Chief Operating Officer

Joseph Mello


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: